Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results

PURPOSE: Results are presented from 2 to 3 trials investigating oral octreotide capsules (OOC) as an alternative to injectable somatostatin receptor ligands (iSRLs) in the treatment of acromegaly. METHODS: CH-ACM-01 was an open-label trial (N = 155) and CHIASMA OPTIMAL was a double-blind placebo-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Labadzhyan, Artak, Nachtigall, L B, Fleseriu, M, Gordon, M B, Molitch, M, Kennedy, L, Samson, S L, Greenman, Y, Biermasz, N, Bolanowski, M, Haviv, A, Ludlam, W, Patou, G, Strasburger, C J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550586/
https://www.ncbi.nlm.nih.gov/pubmed/34173129
http://dx.doi.org/10.1007/s11102-021-01163-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550586/
https://www.ncbi.nlm.nih.gov/pubmed/34173129
http://dx.doi.org/10.1007/s11102-021-01163-2

Ejemplares similares